PRKAR1A Antikörper (N-Term)

Produktnummer ABIN360569

Produktdetails anti-PRKAR1A Antikörper

Target: PRKAR1A (Protein Kinase, CAMP-Dependent, Regulatory, Type I, alpha (Tissue Specific Extinguisher 1) (PRKAR1A))

Bindungsspezifität: N-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PRKAR1A Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)

Spezifität: This antibody reacts to PKR1.

Aufreinigung: Protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS

Immunogen: This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human PKR1.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: ELISA: 1/1,000. Western blotting: 1/100 - 1/500. Immunohistochemistry: 1/50 - 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.25 mg/mL

Buffer: PBS with 0.09 % (W/V) sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.

Details zu PRKAR1A

Target: PRKAR1A (Protein Kinase, CAMP-Dependent, Regulatory, Type I, alpha (Tissue Specific Extinguisher 1) (PRKAR1A))

Andere Bezeichnung: PRKAR1A (PRKAR1A Produkte)

Synonyme: ACRDYS1 antikoerper, ADOHR antikoerper, CAR antikoerper, CNC antikoerper, CNC1 antikoerper, PKR1 antikoerper, PPNAD1 antikoerper, PRKAR1 antikoerper, TSE1 antikoerper, 1300018C22Rik antikoerper, RIalpha antikoerper, Tse-1 antikoerper, Tse1 antikoerper, RIIA antikoerper, prkar1a antikoerper, zgc:92515 antikoerper, im:7047729 antikoerper, cnc1 antikoerper, pkr1 antikoerper, ppnad1 antikoerper, prkar1 antikoerper, tse1 antikoerper, protein kinase cAMP-dependent type I regulatory subunit alpha antikoerper, protein kinase, cAMP dependent regulatory, type I, alpha antikoerper, protein kinase cAMP-dependent type 1 regulatory subunit alpha antikoerper, protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) a antikoerper, cAMP-dependent protein kinase type I-alpha regulatory subunit pseudogene antikoerper, protein kinase cAMP-dependent type I regulatory subunit alpha S homeolog antikoerper, PRKAR1A antikoerper, Prkar1a antikoerper, prkar1aa antikoerper, LOC707275 antikoerper, prkar1a.S antikoerper

Hintergrund: CAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase (AMPK), which transduces the signal through phosphorylation of different target proteins. The inactive holoenzyme of AMPK is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits of AMPK have been identified in humans. PKR1 is one of the regulatory subunits. This protein was found to be a tissue-specific extinguisher that down-regulates the expression of seven liver genes in hepatoma x fibroblast hybrids. Functional null mutations in the gene cause Carney complex (CNC), an autosomal dominant multiple neoplasia syndrome. The gene can fuse to the RET protooncogene by gene rearrangement and form the thyroid tumor-specific chimeric oncogene known as PTC2.Synonyms: CAR, CNC1, PKR1, PRKAR1, TSE1, Tissue-specific extinguisher 1, cAMP-dependent protein kinase type I-alpha regulatory subunit

Gen-ID: 5573, 9606

UniProt: P10644

Pathways: Hedgehog Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma